SCHEMBL1456263

SCHEMBL1456263

CC(C)(CC#N)O[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3099319 0.75
SCHEMBL9594825 0.73
SCHEMBL13531697 0.70
SCHEMBL28070 0.70
SCHEMBL8914737 0.70
SCHEMBL9042428 0.69
SCHEMBL93261 0.69
SCHEMBL1335384 0.69
SCHEMBL20201060 0.69
SCHEMBL2105846 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317161-A1 A PROCESS FOR THE PREPARATION OF PASIREOTIDE AURO PEPTIDES LTD (IN) 2021-10-14 US claimed
EP-3053944-B1 METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR SHINETSU CHEMICAL CO (JP) 2021-10-06 EP claimed
EP-3233899-B1 A PROCESS FOR THE PREPARATION OF PASIREOTIDE AURO PEPTIDES LTD (IN) 2020-06-24 EP claimed
EP-3233899-A1 A PROCESS FOR THE PREPARATION OF PASIREOTIDE Auro Peptides LTD (IN) 2017-10-25 EP claimed
WO-2016097962-A1 A PROCESS FOR THE PREPARATION OF PASIREOTIDE AURO PEPTIDES LTD (IN) 2016-06-23 WO claimed
US-20120214994-A1 (3-FLUORO-2-HYDROXY)PROPYL-FUNCTIONALIZED ARYL DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASES FUTURECHEM CO., LTD. (KR) 2012-08-23 US claimed
EP-1483286-A1 A PROCESS FOR THE PRODUCTION OF RAMOPLANIN-LIKE AMIDE DERIVATIVES Vicuron Pharmaceuticals, Inc. (US) 2004-12-08 EP claimed
WO-2003076460-A1 A PROCESS FOR THE PRODUCTION OF RAMOPLANIN-LIKE AMIDE DERIVATIVES VICURON PHARMACEUTICALS INC. (US) 2003-09-18 WO claimed
US-6534658-B1 Intermediates for producing pharmaceuticals ONO PHARMACEUTICAL CO., LTD. (JP) 2003-03-18 US claimed
US-5212288-A Luteinizing hormone-releasing hormone antagonists SYNTEX (U.S.A.) INC. (US) 1993-05-18 US claimed
EP-0170280-B1 NOVEL INTERMEDIATES AND PROCESS FOR THE PREPARATION OF 3-ACYLAMINO-1-HYDROXY-2-AZETIDINONES E.R. Squibb &amp; Sons, Inc. (US) 1990-12-05 EP claimed
US-4581170-A N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones E. R. SQUIBB & SONS, INC. (US) 1986-04-08 US claimed
EP-0170280-A1 Novel intermediates and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones E.R. Squibb &amp; Sons, Inc. (US) 1986-02-05 EP claimed
CN-118324870-A Improved peptide drugs for insulin resistance 梅德瑞斯糖尿病有限责任公司 2024-07-12 CN disclosed
EP-4397374-A2 IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE Mederis Diabetes, LLC (US) 2024-07-10 EP disclosed
CN-118284434-A Compositions and methods for skipping exon 45 in duchenne muscular dystrophy 恩特拉达治疗学股份有限公司 2024-07-02 CN disclosed
US-4307233-A ANTIBACTERIAL AGENTS RHONE-POULENC INDUSTRIES (FR) 1981-12-22 US disclosed
US-4307230-A ANTIBIOTICS RHONE-POULENC INDUSTRIES (FR) 1981-12-22 US disclosed
US-4278793-A ANTIBIOTICS, BACTERICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-14 US disclosed
US-4128540-A Pyroglutamyl-histidyl-tryptophanyl-seryl-tyrosyl hydrazides PARKE, DAVIS & COMPANY (US) 1978-12-05 US disclosed